(Q40372564)

19 September 2017

title

A novel antiapoptotic mechanism based on interference of Fas signaling by CD44 variant isoforms (English)

1 reference

19 September 2017

Mielgo A

1

1 reference

19 September 2017

van Driel M

2

1 reference

19 September 2017

Bloem A

3

1 reference

19 September 2017

Landmann L

4

1 reference

19 September 2017

Günthert U

5

1 reference

19 September 2017

publication date

1 March 2006

1 reference

Cell Death & Differentiation

19 September 2017

published in

1 reference

19 September 2017

volume

13

1 reference

19 September 2017

issue

3

1 reference

19 September 2017

page(s)

465-477

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cdd.4401763

19 September 2017

exact match

0 references

cites work

CD44 is the principal cell surface receptor for hyaluronate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

CD44: from adhesion molecules to signalling regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

Bimolecular complex between rolling and firm adhesion receptors required for cell arrest; CD44 association with VLA-4 in T cell extravasation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

CD44 is required for two consecutive steps in HGF/c-Met signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

Identification of an active site on the laminin alpha5 chain globular domain that binds to CD44 and inhibits malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

Functional involvement of CD44 variant 7 in gut immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

Effects of anti-CD44 monoclonal antibodies on differentiation and apoptosis of human myeloid leukemia cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

Early detachment of colon carcinoma cells during CD95(APO-1/Fas)-mediated apoptosis. I. De-adhesion from hyaluronate by shedding of CD44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

How did alternative splicing evolve?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

Analysis of CD44-containing lipid rafts: Recruitment of annexin II and stabilization by the actin cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

The death-inducing signalling complex is recruited to lipid rafts in Fas-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

Apoptosis in the development and maintenance of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

A mechanism of cell survival: sequestration of Fas by the HGF receptor Met.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

Cell signalling and the control of pre-mRNA splicing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

Expression and modulation of CD44 variant isoforms in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

Deconvolution improves colocalization analysis of multiple fluorochromes in 3D confocal data sets more than filtering techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

CD44: a multitude of isoforms with diverse functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

7 January 2021

How tumor cells make use of CD44

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

7 January 2021

CD44 isoforms distinguish between bone marrow plasma cells from normal individuals and patients with multiple myeloma at different stages of disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

7 January 2021

CD44 isoforms are differentially regulated in plasma cell dyscrasias and CD44v9 represents a new independent prognostic parameter in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

7 January 2021

Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

7 January 2021

Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401763

7 January 2021

Identifiers

DOI

10.1038/SJ.CDD.4401763

1 reference

Dimensions Publication ID

19 September 2017

1010981483

0 references

1 reference